Ogier in Guernsey advises on MidEuropa's acquisition of Optegra Eye Health Care

Ogier's corporate and funds team in Guernsey has advised MidEuropa on its acquisition of a majority stake in Optegra Eye Health Care.

MidEuropa is a pioneer of private equity in Central Europe, with a successful track record spanning more than 20 years and over €6 billion in funds raised.

Optegra is a leading European ophthalmology platform operating in Poland, Czech Republic, Slovakia and the United Kingdom. It offers a wide range of procedures including cataract, age-related macular degeneration and vision correction for both public and private patients.

The team was led by partner Bryon Rees and included managing associate Michelle Watson Bunn, associate Damian de Klerk and trainee James Hewlett. They advised on all Guernsey law matters related to the acquisition, including corporate, funds and regulatory.

Ogier worked with the lead onshore counsel for MidEuropa, White & Case LLP.